Variants of Traf2 which act as an inhibitor of TNF-ALPHA (TNF alpha) signaling pathway
A Standard patent application filed on 17 August 2005 credited to Searfoss III, George H
;
Clark, Kenneth L
;
Ivashchenko, Yuri D
;
Pagnoni, Marco F
;
Guo, Kun
Details
Application number :
2005203749
Application type :
Standard
Application status :
LAPSED
Under opposition :
No
Proceeding type :
Invention title :
Variants of Traf2 which act as an inhibitor of TNF-ALPHA (TNF alpha) signaling pathway
Inventor :
Searfoss III, George H
;
Clark, Kenneth L
;
Ivashchenko, Yuri D
;
Pagnoni, Marco F
;
Guo, Kun
Agent name :
Watermark Patent and Trade Marks Attorneys
Address for service :
Level 2 302 Burwood Road Hawthorn VIC 3122 Australia
Filing date :
17 August 2005
Associated companies :
Applicant name :
Aventis Pharmaceuticals Inc.
Applicant address :
55 Corporate Drive Bridgewater New Jersey 08807 United States of America